Skip to main content

Table 3 Results of Cox multivariate analysis in the entire patients’ cohort 1

From: Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision

 

Disease free survival

Overall survival

HR

(p)

HR

(p)

Clinical-pathological features

Age

1.93

(0.2)

1.71

(0.3)

Sex

0.70

(0.5)

0.81

(0.7)

Tumour location

1.50

(0.4)

1.85

(0.2)

Tumour grade

1.29

(0.7)

0.81

(0.7)

5-FU treatment

1.23

(0.7)

1.12

(0.8)

Depth of tumour invasion

0.94

(0.9)

1.27

(0.7)

Lymphovascular invasion

0.70

(0.4)

0.61

(0.3)

Large veins invasion

1.08

(0.9)

0.88

(0.8)

Tumour inflammatory response

0.39

(0.06)

0.40

(0.09)

Tumour border configuration

2.77

( 0.06 )

2.91

(0.1)

Molecular parameters

MMR system

1.54

(0.6)

0.97

(1.0)

CIMP

0.58

(0.2)

0.60

(0.3)

TS by mRNA

1.15

(0.7)

1.31

(0.5)

TS by IHC

0.88

(0.8)

0.64

(0.4)

TP53

0.62

(0.2)

0.37

(0.08)

CTNNB1activation grades

0.80

(0.4)

0.90

(0.8)

 

BRAF c.1799 T > A

2.57

(0.04)

3.68

(<0.01)

  1. 1Significant or borderline p values are bolded.